This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

ZIKAVAC (Inactivated Virus)

Bharat Biotech

Drug Names(s): Zika Vaccine, ZIKAVAC

Description: Bharat Biotech is developing ZIKAVAC, a Zika vaccine, using inactivated virus.

ZIKAVAC (Inactivated Virus) News

Pink Sheet Recent And Upcoming FDA Advisory Committee Meetings

Scrip Sanofi And NIH To Test 3-In-1 Antibody In HIV After Monkey Trial Success

Scrip Gritstone Grabs $92.7m To Test Personalized Vaccines In Humans

Scrip Gates Foundation’s $40m Incentivizes Cancer Specialist Immunocore To Develop TB, HIV Drugs

Additional information available to subscribers only:

Targets
Routes
Catalysts
Designations
Events

Request a Free Demo Subscriber Login Search for another drug